sample alt text

It is with great excitement that we invite you to the first Single Day Event (SDE) in several years in South Africa. This event will provide a valuable opportunity for biometrics experts and professionals to share their experiences and network with peers in the field.

Digital transformation is the process of using digital technologies to create new or modify existing business processes, culture, and customer experiences to meet changing business and market requirements. Automation is the use of technology to perform tasks where human input is minimised. Open source refers to any program whose source code is made freely available for use or modification as users or other developers see fit, resulting in an open collaboration. Be part of this pragmatic conversation in Bloemfontein. Come network with and learn from your peers!

Meet Our Team
Pieter Cloete
Sr. Manager, Statistical Programming
Vangeli Grammatikos
Senior Biostatistical Programmer
Burger Lubbe
Statistical Programmer

Schedule A Meeting Now

Please share your details to schedule a meeting with MMS representatives at PHUSE US Connect 2024, and let’s explore a future where accuracy, innovation, and unparalleled expertise drive your success.

Suggested For You

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval